BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8373200)

  • 1. Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction.
    Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
    Arch Biochem Biophys; 1993 Sep; 305(2):606-10. PubMed ID: 8373200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.
    Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
    Arch Biochem Biophys; 1993 Feb; 300(2):756-60. PubMed ID: 8434953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction.
    Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
    Biochem Biophys Res Commun; 1993 May; 192(3):1409-14. PubMed ID: 8389550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
    Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
    J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of retroviral integrase by fusion to a heterologous DNA binding domain: in vitro activities and incorporation of a fusion protein into viral particles.
    Katz RA; Merkel G; Skalka AM
    Virology; 1996 Mar; 217(1):178-90. PubMed ID: 8599202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interactions of HIV-1 DNA heterocyclic bases with viral DNA].
    Agapkina IuIu; Tashlitskiĭ VN; Deprez E; Brochon JC; Shugaliĭ AV; Mouscadet JF; Gottikh MB
    Mol Biol (Mosk); 2004; 38(5):848-57. PubMed ID: 15554187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.
    Leavitt AD; Rose RB; Varmus HE
    J Virol; 1992 Apr; 66(4):2359-68. PubMed ID: 1548767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 integrase stabilizes a linearized HIV-1 LTR plasmid in vivo.
    Faust EA; Acel A; Udashkin B; Wainberg MA
    Biochem Mol Biol Int; 1995 Jul; 36(4):745-58. PubMed ID: 8528137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus DNA termini bound by integrase communicate in trans for full-site integration in vitro.
    McCord M; Chiu R; Vora AC; Grandgenett DP
    Virology; 1999 Jul; 259(2):392-401. PubMed ID: 10388663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional nucleotides of U5 LTR determining substrate specificity of prototype foamy virus integrase.
    Kang SY; Ahn DG; Lee C; Lee YS; Shin CG
    J Microbiol Biotechnol; 2008 Jun; 18(6):1044-9. PubMed ID: 18600045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.
    Esposito D; Craigie R
    EMBO J; 1998 Oct; 17(19):5832-43. PubMed ID: 9755183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity of recombinant human immunodeficiency virus integrase protein.
    LaFemina RL; Callahan PL; Cordingley MG
    J Virol; 1991 Oct; 65(10):5624-30. PubMed ID: 1895409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.
    Tramontano E; Onidi L; Esposito F; Badas R; La Colla P
    Biochem Pharmacol; 2004 May; 67(9):1751-61. PubMed ID: 15081874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Moloney murine leukemia virus integration using polyamides targeting the long-terminal repeat sequences.
    Yang F; Belitsky JM; Villanueva RA; Dervan PB; Roth MJ
    Biochemistry; 2003 May; 42(20):6249-58. PubMed ID: 12755629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
    Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 proviral DNA excision using an evolved recombinase.
    Sarkar I; Hauber I; Hauber J; Buchholz F
    Science; 2007 Jun; 316(5833):1912-5. PubMed ID: 17600219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Displacement of viral DNA termini from stable HIV-1 integrase nucleoprotein complexes induced by secondary DNA-binding interactions.
    Pemberton IK; Buc H; Buckle M
    Biochemistry; 1998 Feb; 37(8):2682-90. PubMed ID: 9485419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triplex-mediated inhibition of HIV DNA integration in vitro.
    Mouscadet JF; Carteau S; Goulaouic H; Subra F; Auclair C
    J Biol Chem; 1994 Aug; 269(34):21635-8. PubMed ID: 8063805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cluster of strong topoisomerase II cleavage sites is located near an integrated human immunodeficiency virus.
    Howard MT; Griffith JD
    J Mol Biol; 1993 Aug; 232(4):1060-8. PubMed ID: 8396647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc stimulates Mg2+-dependent 3'-processing activity of human immunodeficiency virus type 1 integrase in vitro.
    Lee SP; Han MK
    Biochemistry; 1996 Mar; 35(12):3837-44. PubMed ID: 8620007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.